• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Targeting Intimin for Removal of Enteropathogenic E. coli

Gabriel Nunez of the University of Michigan in the U.S. will investigate whether inhibiting intimin, a virulence factor protein of E. coli, can help clear the bacteria from infected patients. Intimin helps the pathogen adhere to intestinal epithelial cells to cause virulence, but if intimin is inhibited the pathogen will relocate to the intestinal lumen, where it can be outcompeted by commensal bacteria.

More information about Explore New Solutions for Global Health Priority Areas (Round 9)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.